Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
NCT00758771 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2014-03-05
Summary
The purpose of this study is to characterize the rheological properties of cystic fibrosis (CF) and healthy sputum and to examine the effects of mucoactive agents on the rheology of CF and healthy sputum. By collaborating with Genentech, the investigators (scientists at UCSF) plan to incorporate the latest scientific findings into our work to discover and develop new treatments for CF.
Conditions
Sponsors & Collaborators
-
Genentech, Inc.
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Costimulatory Molecules as Biomarkers in Cystic Fibrosis
NCT01353950 ·Status: COMPLETED
-
A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)
NCT01626157 ·Status: COMPLETED
-
Mucin in Sputum of CF During Pulmonary Exacerbation
NCT00202072 ·Status: UNKNOWN
-
Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis
NCT01031706 ·Status: COMPLETED ·Phase: NA
-
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
NCT01973192 ·Status: COMPLETED
-
Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis
NCT01753869 ·Status: TERMINATED ·Phase: NA
-
A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome
NCT05088447 ·Status: TERMINATED
-
Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis
NCT03684759 ·Status: COMPLETED
-
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
NCT00750932 ·Status: COMPLETED
-
Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation
NCT02480270 ·Status: COMPLETED
-
Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia
NCT01155115 ·Status: COMPLETED ·Phase: NA
-
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
NCT05392855 ·Status: TERMINATED ·Phase: NA
-
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
NCT07312734 ·Status: NOT_YET_RECRUITING
-
A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic Fibrosis
NCT01923753 ·Status: TERMINATED ·Phase: PHASE2
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
NCT03000348 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway
NCT00248755 ·Status: COMPLETED ·Phase: NA
-
The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis
NCT00271310 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis
NCT05740618 ·Status: COMPLETED ·Phase: PHASE4
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
NCT02965326 ·Status: RECRUITING ·Phase: NA
-
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
NCT02769637 ·Status: TERMINATED
-
The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective
NCT01306279 ·Status: COMPLETED
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Regional Phenotyping of CF and Non-CF Bronchiectasis
NCT04793867 ·Status: RECRUITING